Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of low- and high-dose slow oral egg immunotherapy for hen's egg allergy: Single-center non-inferiority randomized trial.
Takaoka Y, Ito YM, Kumon J, Yamaguchi T, Ueno R, Tsurinaga Y, Nakano T, Fukasawa Y, Shigekawa A, Yoshida Y, Kameda M, Doi S. Takaoka Y, et al. Among authors: tsurinaga y. Asian Pac J Allergy Immunol. 2023 Apr 17. doi: 10.12932/AP-130722-1411. Online ahead of print. Asian Pac J Allergy Immunol. 2023. PMID: 37061933 Free article.
Effectiveness and Safety of Double-Blind, Placebo-Controlled, Low-Dose Oral Immunotherapy with Low Allergen Egg-Containing Cookies for Severe Hen's Egg Allergy: A Single-Center Analysis.
Takaoka Y, Maeta A, Takahashi K, M Ito Y, Takahashi S, Muroya T, Shigekawa A, Tsurinaga Y, Iba N, Yoshida Y, Kameda M, Doi S. Takaoka Y, et al. Among authors: tsurinaga y. Int Arch Allergy Immunol. 2019;180(4):244-249. doi: 10.1159/000502956. Epub 2019 Oct 2. Int Arch Allergy Immunol. 2019. PMID: 31578023
Single-Center Noninferiority Randomized Trial on the Efficacy and Safety of Low- and High-Dose Rush Oral Milk Immunotherapy for Severe Milk Allergy.
Takaoka Y, Yajima Y, Ito YM, Kumon J, Muroya T, Tsurinaga Y, Shigekawa A, Takahashi S, Iba N, Tsuji T, Nishikido T, Yoshida Y, Doi S, Kameda M. Takaoka Y, et al. Among authors: tsurinaga y. Int Arch Allergy Immunol. 2020;181(9):699-705. doi: 10.1159/000508627. Epub 2020 Jun 22. Int Arch Allergy Immunol. 2020. PMID: 32570237 Clinical Trial.
Two Pediatric Cases of Primary Ciliary Dyskinesia Caused by Loss-of-Function Variants in Oral-Facial-Digital Syndrome Gene, OFD1.
Xu Y, Tsurinaga Y, Matsumoto T, Muta R, Yano T, Sakaida H, Masuda S, Ueda K, Feng G, Gotoh S, Ogawa S, Ikejiri M, Nakatani K, Nagao M, Tanabe M, Takeuchi K. Xu Y, et al. Among authors: tsurinaga y. Case Rep Genet. 2024 Aug 9;2024:1595717. doi: 10.1155/2024/1595717. eCollection 2024. Case Rep Genet. 2024. PMID: 39156004 Free PMC article.
Suppressed pediatric asthma hospitalizations during the COVID-19 pandemic in Japan, from a national survey.
Korematsu S, Fujisawa T, Saito N, Tezuka J, Miura K, Kobayashi I, Miyata I, Kosugi Y, Gohda Y, Koike Y, Suda A, Matsuo A, Sasaki M, Handa Y, Fujiwara M, Ono A, Koizumi S, Oishi T, Tanaka T, Ando Y, Taba N, Tsurinaga Y, Sato T, Kanai R, Yashiro M, Takagi T, Hida S, Harazaki M, Hoshina T, Okada S, Yasutomi M, Nakata S, Muto A, Tanabe S, Ueda Y, Hasegawa S, Kameda M, Tanaka-Taya K, Fujimoto T, Okada K. Korematsu S, et al. Among authors: tsurinaga y. Clin Transl Allergy. 2024 Jan;14(1):e12330. doi: 10.1002/clt2.12330. Clin Transl Allergy. 2024. PMID: 38282201 Free PMC article.